Jane Mason

Consultant Haematologist and Director
Queensland Haemophilia Centre, Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
Brisbane, Queensland, Australia

Presentation(s):

• OC 20.1 - Bleeding, FVIII activity, and safety 3 years after gene transfer with valoctocogene roxaparvovec: Results from GENEr8-1

  Sunday, June 25, 2023
  14:45 – 15:00 ET

• OC 77.2 - Discrepant low ACL TOP VWF:GP1bR result is frequent in unselected MPN patients and does not predict bleeding risk

  Wednesday, June 28, 2023
  10:30 – 10:45 ET